<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.8" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-8.xsd">
  <titleInfo>
    <title>Arrhythmias analysis in post myocardial infarction CABG and CD133+ bone marrow stem cell therapy PERFECT RCT phase III</title>
  </titleInfo>
  <titleInfo type="alternative">
    <title>Coronary artery bypass grafting randomized clinical trial</title>
  </titleInfo>
  <name type="personal" usage="primary">
    <namePart>Abdelhalim, Mohamed</namePart>
    <namePart type="date">1985-</namePart>
    <role>
      <roleTerm type="text">VerfasserIn</roleTerm>
    </role>
    <role>
      <roleTerm authority="marcrelator" type="code">aut</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Steinhoff, Gustav</namePart>
    <namePart type="date">1958-</namePart>
    <role>
      <roleTerm type="text">AkademischeR BetreuerIn</roleTerm>
    </role>
    <role>
      <roleTerm authority="marcrelator" type="code">dgs</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Ortak, Jasmin</namePart>
    <namePart type="date">1977-</namePart>
    <role>
      <roleTerm type="text">AkademischeR BetreuerIn</roleTerm>
    </role>
    <role>
      <roleTerm authority="marcrelator" type="code">dgs</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Bergmann, Olaf Ingmar</namePart>
    <namePart type="date">1977-</namePart>
    <role>
      <roleTerm type="text">AkademischeR BetreuerIn</roleTerm>
    </role>
    <role>
      <roleTerm authority="marcrelator" type="code">dgs</roleTerm>
    </role>
  </name>
  <name type="corporate">
    <namePart>Universität Rostock</namePart>
    <role>
      <roleTerm type="text">Grad-verleihende Institution</roleTerm>
    </role>
    <role>
      <roleTerm authority="marcrelator" type="code">dgg</roleTerm>
    </role>
  </name>
  <name type="corporate">
    <namePart>Universitätsmedizin Rostock</namePart>
    <role>
      <roleTerm type="text">Grad-verleihende Institution</roleTerm>
    </role>
    <role>
      <roleTerm authority="marcrelator" type="code">dgg</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marcgt">theses</genre>
  <genre authority="rdacontent">Text</genre>
  <genre authority="gnd-content">Hochschulschrift</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">gw</placeTerm>
    </place>
    <dateIssued encoding="marc">2021</dateIssued>
    <issuance>monographic</issuance>
    <place>
      <placeTerm type="code" authority="iso3166">XA-DE</placeTerm>
    </place>
  </originInfo>
  <originInfo eventType="publication">
    <place>
      <placeTerm type="text">Rostock</placeTerm>
    </place>
    <agent>
      <namePart>Universität</namePart>
      <role>
        <roleTerm>publisher</roleTerm>
      </role>
    </agent>
    <dateIssued>2021</dateIssued>
  </originInfo>
  <originInfo eventType="distribution">
    <place>
      <placeTerm type="text">Rostock</placeTerm>
    </place>
    <agent>
      <namePart>Universitätsbibliothek</namePart>
      <role>
        <roleTerm>distributor</roleTerm>
      </role>
    </agent>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marccategory">electronic resource</form>
    <form authority="marcsmd">remote</form>
    <form type="media" authority="rdamedia">Computermedien</form>
    <form type="carrier" authority="rdacarrier">Online-Ressource</form>
    <extent>1 Online-Ressource</extent>
  </physicalDescription>
  <abstract type="Summary">This study investigates the safety of stem cell therapy combined with CABG to improve myocardial function after myocardial infarction. The patient groups of the PERFECT RCT Phase III were further analyzed in the scope of this work to placebo, stem cell, responder and non-responder groups. The outcome of this analysis showed an increase in the incidence rate of non-serious arrhythmias (SVES and VES) in stem cell group but also showed a significant reduction in this incidence rate over a period of time of up to 180 days only in the responder subgroup to the therapy.&lt;eng&gt;</abstract>
  <abstract type="Summary">Diese Arbeit untersucht die Sicherheit der Stammzelltherapie in Kombination mit ACB-OP nach Myokardinfarkt. Die Pantienten der RCT PERFECT Phase III wurden in Placebo-, Stammzell-, Responder- und non-Respondergruppe unterteilt. Das Ergebnis dieser Analyse zeigte zwar einen Anstieg der Inzidenzrate nicht schwerwiegender Arrhythmien (SVES und VES) in Stammzellenguppe, zeigte jedoch auch eine signifikante Verringerung dieser Inzidenzrate über einen Zeitraum von bis zu 180 Tagen nur in der Responder-Subgruppe.&lt;ger&gt;</abstract>
  <note type="statement of responsibility">vorgelegt von Mohamed Abdelhalim</note>
  <note>GutachterInnen: Gustav Steinhoff (Klinik für Herzchirurgie, Universitätsmedizin Rostock) ; Jasmin Ortak (Rhythmologie und Klinische Elektrophysiologie, Universitätsmedizin Rostock) ; Olaf Bergmann (Technische Universität Dresden, Center for Regenerative Therapies Dresden)</note>
  <note type="thesis">Dissertation Universität Rostock 2022</note>
  <classification authority="ddc">610</classification>
  <classification authority="ddc">616.1</classification>
  <classification authority="ddc">610</classification>
  <classification authority="rvk">YB 9515</classification>
  <classification authority="bkl">44.85</classification>
  <location>
    <url displayLabel="electronic resource" usage="primary display" note="kostenfrei">http://purl.uni-rostock.de/rosdok/id00003774</url>
  </location>
  <location>
    <url displayLabel="electronic resource" note="kostenfrei">https://doi.org/10.18453/rosdok_id00003774</url>
  </location>
  <location>
    <url displayLabel="electronic resource" note="kostenfrei">https://nbn-resolving.org/urn:nbn:de:gbv:28-rosdok_id00003774-5</url>
  </location>
  <location>
    <url displayLabel="electronic resource" note="kostenfrei">https://d-nb.info/1293538043/34</url>
  </location>
  <relatedItem type="otherFormat" otherType="Erscheint auch als" displayLabel="Erscheint auch als">
    <titleInfo>
      <title>Arrhythmias analysis in post myocardial infarction CABG and CD133+ bone marrow stem cell therapy PERFECT RCT phase III</title>
    </titleInfo>
    <originInfo>
      <publisher>Rostock, 2021</publisher>
    </originInfo>
    <physicalDescription>
      <form>XI, 93 Seiten</form>
    </physicalDescription>
    <note>Druckausgabe</note>
    <identifier type="local">(DE-627)181073309X</identifier>
    <name>
      <namePart>Abdelhalim, Mohamed, 1985 - </namePart>
    </name>
  </relatedItem>
  <identifier type="urn">urn:nbn:de:gbv:28-rosdok_id00003774-5</identifier>
  <identifier type="doi">10.18453/rosdok_id00003774</identifier>
  <identifier type="oclc">1335551247</identifier>
  <recordInfo>
    <descriptionStandard>rda</descriptionStandard>
    <recordContentSource authority="marcorg">DE-627</recordContentSource>
    <recordCreationDate encoding="marc">220713</recordCreationDate>
    <recordIdentifier source="DE-627">181010629X</recordIdentifier>
    <recordChangeDate encoding="iso8601">20251226T203207.0</recordChangeDate>
    <recordOrigin>Converted from MARCXML to MODS version 3.8 using MARC21slim2MODS3-8_XSLT1-0.xsl
				(Revision 1.174 20250328)</recordOrigin>
    <languageOfCataloging>
      <languageTerm authority="iso639-2b" type="code">ger</languageTerm>
    </languageOfCataloging>
  </recordInfo>
</mods>
